# Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy

> **NCT06615908** · PHASE1 · RECRUITING · sponsor: **University of Calgary** · enrollment: 40 (estimated)

## Conditions studied

- Persisting Symptoms After Concussion

## Interventions

- **DRUG:** Psilocybin

## Key facts

- **NCT ID:** NCT06615908
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2026-10-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06615908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06615908, "Treatment of Persisting Symptoms After Concussion With Psilocybin Assisted Therapy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06615908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*